{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:46:20Z","timestamp":1792176380875,"version":"4.4.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"J. Arch McNamara MD Fund for Retina Research and Education"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41433-026-04848-9","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:36:05Z","timestamp":1788975365000},"page":"2319-2320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The rationale for ophthalmic vigilance during the 2026 Hantavirus outbreak"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-8962","authenticated-orcid":false,"given":"Aaron T.","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3899-4456","authenticated-orcid":false,"given":"Jordan D.","family":"Deaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"4848_CR1","unstructured":"Group AVOW. Andes Hantavirus Outbreak on a Cruise Ship, 2026. New England Journal of Medicine 2026;0."},{"key":"4848_CR2","unstructured":"2026 Hantavirus Outbreak: Testing for Potential Infection. May 18, 2026. Available at: https:\/\/www.cdc.gov\/han\/php\/notices\/han00529.html. Accessed May 22, 2026."},{"key":"4848_CR3","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa2009040","volume":"383","author":"VP Mart\u00ednez","year":"2020","unstructured":"Mart\u00ednez VP, Paola ND, Alonso DO, P\u00e9rez-Sautu U, Bellomo CM, Iglesias AA, et al. \"Super-Spreaders\u201d and person-to-person transmission of andes virus in Argentina. N Engl J Med. 2020;383:2230\u201341.","journal-title":"N Engl J Med"},{"key":"4848_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1136\/bjo.2010.185413","volume":"95","author":"N Hautala","year":"2011","unstructured":"Hautala N, Kauma H, Vapalahti O, M\u00e4h\u00f6nen SM, Vainio O, Vaheri A, et al. Prospective study on ocular findings in acute Puumala hantavirus infection in hospitalised patients. Br J Ophthalmol. 2011;95:559\u201362.","journal-title":"Br J Ophthalmol"},{"key":"4848_CR5","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/v13061040","volume":"13","author":"N Hautala","year":"2021","unstructured":"Hautala N, Partanen T, Kubin A-M, Kauma H, Hautala T. Central nervous system and ocular manifestations in Puumala Hantavirus Infection. Viruses. 2021;13:1040.","journal-title":"Viruses"},{"key":"4848_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1600-0420.1996.tb00748.x","volume":"74","author":"M Kontkanen","year":"1996","unstructured":"Kontkanen M, Puustj\u00e4rvi T, Kauppi P, L\u00e4hdevirta J. Ocular characteristics in nephropathia epidemica or Puumala virus infection. Acta Ophthalmol Scand. 1996;74:621\u20135.","journal-title":"Acta Ophthalmol Scand"},{"key":"4848_CR7","unstructured":"Clinician Brief: Hantavirus Pulmonary Syndrome (HPS). Centers for Disease Control and Prevention. Available at: https:\/\/www.cdc.gov\/hantavirus\/hcp\/clinical-overview\/hps.html. Accessed May 21, 2026."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04848-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04848-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04848-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:55:44Z","timestamp":1792173344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04848-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":7,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4848"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04848-9","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"20 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JD: Consultant for Abbvie, ANI, Bausch + Lomb, EyePoint, Genentech, Regeneron; Speakers Bureau for ANI, Bausch + Lomb.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}